Dear Colleagues and Friends,

We are delighted to announce the 5th EUNETHYDIS International Conference on ADHD. This conference will be held in Edinburgh, Scotland from Sunday 23rd to Wednesday 26th September 2018.

The J-EUNETHYDIS International Conference will take place on Sunday 23rd September 2018.

In collaboration with UKAAN (UK Adult ADHD Network), we are also planning to run a Clinical Study Day on Sunday 23rd September 2018 that will focus on the recognition and management of ADHD in adults. This meeting is not part of the Main Conference and details on how to register, for this stand-alone meeting, will be available shortly on this website.

In the tradition of EUNETHYDIS meetings, our primary focus will be on ADHD and associated conditions. The ultimate objective of our work is always focused on improving the lives of those with ADHD and of those around them. In order to do this, we need to conduct basic scientific work to help us better understand the nature of ADHD and its causes in order to stimulate therapeutic innovation and hopefully in the longer term develop ways to base diagnosis and treatment on a strong theoretical foundation. From a clinical perspective we need to not only develop our understanding of what works and for whom but also to roll this evidence out into day to day clinical practice.

This conference will encourage the exchange of ideas and data to further our collaboration between scientists and clinicians; it is only by working together in this way that we can improve the care of our patients with ADHD and their families.

We have gathered together a global faculty of leading experts in ADHD and associated conditions who will be presenting an exciting and, at times, challenging programme of plenary sessions and satellite symposia. We are working hard with them to ensure that their presentations will focus on key issues relevant to delivering every day ‘evidence based’ clinical practice. In addition, there will be opportunities for you to work and network with your colleagues and internationally renowned experts in ADHD, across the life-span.

Key themes will cover a broad range of ‘scientific and clinical hot topics’ and will include:

ADHD across the lifespan, ADHD in adults, new treatment options – pharmacological and non-pharmacological, tailoring of treatment/precision, ADHD and comorbidities, clinical implementation of guidelines, ADHD in preschoolers, transition from adolescents to adults and ICD-11 and DSM-5 implications

We hope you will join us for what promises to be an informative and enjoyable conference and we look forward to seeing you in Edinburgh.

Kind regards,

Tobias Banaschewski

Chairman, Eunethydis Network

Chair of Child and Adolescent Psychiatry, Medical Faculty Mannheim of the University Heidelberg, Germany

David Coghill

Chairman, Eunethydis International Conferences

Financial Markets Foundation Chair of Developmental Mental Health, University of Melbourne, Australia

Professor of Child and Adolescent Psychiatry, Royal Children’s Hospital Melbourne, Australia